Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Notable: TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone · Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response Start date pushed from Sep 2026 to Nov 2026 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 3 NCT07797231
  2. Notable: S-606001 · Late-onset Pompe Disease (LOPD) Start date pushed from Nov 2, 2026 to Mar 31, 2027 ShionogiPhase 2 NCT07750990
  3. Notable: Urine Volatile Organic Compounds for Disease Detection Eligibility criteria changed Toby, Inc.Not specified NCT07933042
  4. Notable: Epcoritamab as Consolidative Therapy for Waldenstr(SqrRoot)(Delta)m Macroglobulinemia (WM) Treated With a Bruton Tyrosine Kinase Inhibitor (BTKi) Eligibility criteria changed National Heart, Lung, and Blood Institute (NHLBI)Phase 2 NCT07882173
  5. Notable: Quanduzhong Capsules for Primary Osteoporosis Start date pushed from Oct 15, 2026 to Dec 15, 2026 Shanghai University of Traditional Chinese MedicinePhase 3 NCT07895082
  6. Notable: LLM-Generated Medical Summaries During Hospitalization to Improve Patient Activation in High-Risk Pregnancies Start date pushed from Oct 1, 2026 to Dec 1, 2026 Sheba Medical CenterNot applicable NCT07823517
  7. Notable: Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study Enrollment increased: 1 → 946 participants National Cancer Institute (NCI)Not specified NCT03309033
  8. Notable: Rapamycin in Ovarian Aging Results posted: Nov 18, 2026 Columbia UniversityPhase 2 NCT05836025
  9. Notable: LM11A-31 Safety and Tolerability in Aging People Living With HIV and Neurocognitive Impairment Eligibility criteria changed University of North Carolina, Chapel HillPhase 1/2 NCT07934186
  10. Notable: PPIs and In-Hospital Morbidity in Acute Variceal Bleeding With Chronic Liver Disease Enrollment increased: 80 → 120 participants Universidad Autonoma de Nuevo LeonPhase 2 NCT06861478
  11. Notable: Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome Start date pushed from Sep 2026 to Nov 30, 2026 Seoul National University Bundang HospitalPhase 4 NCT07799779
  12. Notable: GMDTC Injection · Solid Tumors and Cisplatin-Induced Renal Dysfunction Start date pushed from Oct 2026 to Dec 2026 Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.Phase 1 NCT07824843
  13. Notable: Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer Primary completion date changed from estimate of Jan 1, 2026 to Nov 1, 2026 Anthony Joshua, FRACPPhase 1 NCT05156892
  14. Notable: Topical CBD Scar Healing Study Start date pushed from Sep 2026 to Dec 2026 University of OklahomaPhase 1 NCT06129591
  15. Notable: [18F]ZDG2 First-in-Human PET Imaging in PAH Eligibility criteria changed The Methodist Hospital Research InstituteEarly Phase 1 NCT07934264
  16. Notable: De-escalation of Axillary Dissection for Node-positive Breast Cancer Start date pushed from Oct 15, 2026 to Jan 15, 2027 University of NebraskaNot applicable NCT07856160
  17. Notable: Piloting FUERTE · Federally qUalified Health Centers Engaging Hispanic Men at Risk of diabeTEs Start date pushed from Oct 2026 to Dec 2026 Weill Medical College of Cornell UniversityNot applicable NCT07878806
  18. Notable: Advancing Cardiovascular Health · Intellectual Disabilities: Co-Development of Technology Interventions to Enhance Physical Activity Start date pushed from Nov 30, 2026 to Jun 30, 2027 Michigan State UniversityNot applicable NCT07919171
  19. Notable: Sight and Hearing Investigation Into Effects on Delirium Results posted: Nov 18, 2026 Johns Hopkins UniversityNot specified NCT06176625
  20. Notable: Rotational Atherectomy and Drug-Coated Balloon Angioplasty With Embolic Protection for Superficial Femoral Artery Occlusions Start date pushed from Sep 1, 2026 to Dec 1, 2026 Sakarya UniversityNot applicable NCT07803718
  21. Notable: Acceptability of AI-Personalized Virtual Reality Picture Books for Hospitalized Pediatric Patients Start date pushed from Oct 1, 2026 to Nov 30, 2026 Stanford UniversityNot applicable NCT07637617
  22. Notable: Walking Balance Training Post-Stroke Results posted: Nov 18, 2026 Northwestern UniversityNot applicable NCT06090604
  23. Notable: Mobile Contingency Management for Smoking Cessation Results posted: Nov 18, 2026 University of OklahomaNot applicable NCT04881630
  24. Notable: Management of Intractable Trigeminal Neuralgia of Multiple Sclerosis Patients <Bassiouni Technique> Start date pushed from Aug 31, 2026 to Nov 29, 2026 Assiut UniversityNot applicable NCT07811973
  25. Notable: Serum Electrolytes and Contrast-Induced Nephropathy in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment Primary completion date changed from estimate of May 10, 2026 to Nov 10, 2026 Saglik Bilimleri Universitesi Gazi Yasargil Training and Research HospitalNot specified NCT07546448